Compare Dow Jones Industrial Average ETF (DIA) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Jones Industrial Average ETF vs Nuwellis Inc — how do they compare? Dow Jones Industrial Average ETF trades at $512.97 (market cap $45.20B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Dow Jones Industrial Average ETF is far larger — about 20545.5× Nuwellis Inc's market cap, and Dow Jones Industrial Average ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dow Jones Industrial Average ETF for 103 Days and Nuwellis Inc for 26 Days on average.
| DIA | NUWE | |
|---|---|---|
Market Cap | $45.20B | $2.20M |
Volume | 4,095,368 | 121,544 |
52-Week High | $542.79 | $146.65 |
52-Week Low | $451.37 | $0.68 |
Typical Hold Time | 103 Days | 26 Days |
Sector | — | Health |
Enterprise Value | — | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DIA trades at $511.02, down 0.68% with bearish technical signals from moving averages. The ETF shows neutral oscillator readings but faces selling pressure according to ADX indicators. Recent dividend distributions provide income appeal, though key valuation metrics remain unavailable. Support levels cluster around $506-509 while resistance sits at $512-516.
The ETF faces near-term headwinds from technical weakness and broader market volatility. Dividend payments offer income stability, but lack of fundamental metrics limits valuation assessment. Market sentiment remains cautious amid economic uncertainty and Fed policy concerns.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dow Jones Industrial Average ETF
The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on DIA →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
